Curatis Holding AG (XSWX:CURN) Interest Expense : CHF-0.02 Mil (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Curatis Holding AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Curatis Holding AG's interest expense for the six months ended in Jun. 2024 was CHF -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was CHF-0.02 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Curatis Holding AG's Operating Income for the six months ended in Jun. 2024 was CHF -3.30 Mil. Curatis Holding AG's Interest Expense for the six months ended in Jun. 2024 was CHF -0.01 Mil. Curatis Holding AG did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Curatis Holding AG Interest Expense Historical Data

The historical data trend for Curatis Holding AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Interest Expense Chart

Curatis Holding AG Annual Data

Trend

Dec21

Dec22

Dec23

Interest Expense

-0.01

Curatis Holding AG Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial			-	-	-	-0.01	-0.01

Curatis Holding AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-0.02 Mil.

Curatis Holding AG (XSWX:CURN) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Curatis Holding AG's Interest Expense for the six months ended in Jun. 2024 was CHF-0.01 Mil. Its Operating Income for the six months ended in Jun. 2024 was CHF-3.30 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was CHF0.00 Mil.

Curatis Holding AG's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Curatis Holding AG did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Curatis Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

CURNz:UK

Address

Weierweg 7, Liestal, CHE, CH-4410

Website

https://www.curatis.com

Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.